Ignite Creation Date:
2024-05-06 @ 2:42 PM
Last Modification Date:
2024-10-26 @ 1:36 PM
Study NCT ID:
NCT04407988
Status:
UNKNOWN
Last Update Posted:
2021-10-13
First Post:
2020-05-25
Brief Title:
Pyrotinib in Combination With Letrozole in Patients With HER2-Positive ER-Positive Metastatic Breast Cancer
Sponsor:
Hunan Cancer Hospital
Organization:
Hunan Cancer Hospital
Organization Data
Organization:
Hunan Cancer Hospital
Class:
OTHER
Study ID:
HR-BLTN-008
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Hunan Cancer Hospital
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Jiangsu HengRui Medicine Co Ltd | INDUSTRY |